| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745900 | Parkinsonism & Related Disorders | 2011 | 5 Pages |
Abstract
The main motivations of PD patients to participate in CTs were the benefit to the patient himself and to others. The major concern was safety. PD patients understood the informed consent, but more educational efforts must be made to explain the placebo effect. Most PD patients were very positive toward CTs and would participate in another trial.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Anabela Valadas, Miguel Coelho, Tiago Mestre, Leonor Correia Guedes, Maria Finisterra, Ana Noronha, Mário M. Rosa, Cristina Sampaio, Joaquim J. Ferreira,